BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

984 related articles for article (PubMed ID: 26184978)

  • 1. MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.
    Xu Z; Han Y; Liu J; Jiang F; Hu H; Wang Y; Liu Q; Gong Y; Li X
    Sci Rep; 2015 Jul; 5():12276. PubMed ID: 26184978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.
    Zhang R; Sui L; Hong X; Yang M; Li W
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22294-22300. PubMed ID: 28799067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-155-5p inhibits the proliferation and migration of VSMCs and HUVECs in atherosclerosis by targeting AKT1.
    Chen L; Zheng SY; Yang CQ; Ma BM; Jiang D
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2223-2233. PubMed ID: 30915770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1.
    Li M; Liu Q; Lei J; Wang X; Chen X; Ding Y
    Biochem Biophys Res Commun; 2017 Nov; 493(1):270-276. PubMed ID: 28890348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-520c-3p targeting of RelA/p65 suppresses atherosclerotic plaque formation.
    Wang J; Hu X; Hu X; Gao F; Li M; Cui Y; Wei X; Qin Y; Zhang C; Zhao Y; Gao Y
    Int J Biochem Cell Biol; 2021 Feb; 131():105873. PubMed ID: 33166679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CASC2 inhibits ox-LDL-mediated vascular smooth muscle cells proliferation and migration via the regulation of miR-532-3p/PAPD5.
    Wang C; Zhao J; Nan X; Guo Z; Huang S; Wang X; Sun F; Ma S
    Mol Med; 2020 Jul; 26(1):74. PubMed ID: 32698757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
    de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
    Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOXL1-AS1/miR-515-5p/STAT3 Positive Feedback Loop Facilitates Cell Proliferation and Migration in Atherosclerosis.
    Xie Q; Li F; Shen K; Luo C; Song G
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):151-158. PubMed ID: 32453072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-128-3p inhibits vascular smooth muscle cell proliferation and migration by repressing FOXO4/MMP9 signaling pathway.
    Qu C; Liu X; Guo Y; Fo Y; Chen X; Zhou J; Yang B
    Mol Med; 2020 Nov; 26(1):116. PubMed ID: 33238881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircMAPK1 promotes the proliferation and migration of vascular smooth muscle cells through miR-22-3p/ methyl-CpG binding protein 2 axis.
    Fu X; Niu T; Yang T; Li X
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2189-2198. PubMed ID: 34059381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-147b influences vascular smooth muscle cell proliferation and migration via targeting YY1 and modulating Wnt/β-catenin activities.
    Yue Y; Lv W; Zhang L; Kang W
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):905-913. PubMed ID: 30060075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
    Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
    Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-29a-3p Suppresses Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells in Atherosclerosis via Targeting TNFRSF1A.
    You L; Chen H; Xu L; Li X
    Biomed Res Int; 2020; 2020():9627974. PubMed ID: 32964047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
    Wang J; Yan CH; Li Y; Xu K; Tian XX; Peng CF; Tao J; Sun MY; Han YL
    Exp Cell Res; 2013 May; 319(8):1165-75. PubMed ID: 23518389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-140-5p regulates vascular smooth muscle cell viability, migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis.
    Luo Y; Li Y; Peng H; Zhao Y
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.
    Reddy MA; Das S; Zhuo C; Jin W; Wang M; Lanting L; Natarajan R
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):864-73. PubMed ID: 26941017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation.
    Zhu J; Liu B; Wang Z; Wang D; Ni H; Zhang L; Wang Y
    Theranostics; 2019; 9(23):6901-6919. PubMed ID: 31660076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 50.